TIANJIN PHARM DA REN TANG GRP
(SGX: T14)

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

2.000 -

+0.030 (+1.52%)
价格区间 1.960 - 2.010   (2.55%)
开盘 2.000
昨收 1.970
1.990
买盘 ('000) 17.6
2.000
卖盘 ('000) 18
成交量 ('000) 400.9
成交额 801,545
注释 -
数据延迟。最后一次更新26 Apr 2024 17:06.
数据提供商

未来大事

AGM

会议日期 15 May 2024
会议时间 1:30 PM
1.30 P.M. AT THE MEETING ROOM OF THE COMPANY S MODERN TRADITIONAL CHINESE MEDICINE INDUSTRIAL PARK LOCATED (CONCURRENTLY, A VIDEO CONFERENCING AT LIBRARY 1 & 2, LEVEL 8, 1 PICKERING STREET, GREAT EASTERN CENTRE, SINGAPORE 048659 FOR HOLDERS OF THE S-SHARES IN SINGAPORE).
数据由SGX提供支持。
查看所有活动

关于 TJ DaRenTang USD

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

Loading Chart...

Please login to view stock data and analysis